↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

50 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   ACR-16  0件:   -   -   -   1件:
8
 2   Alprazolam  1件: Alprazolam;   D00225   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   1件:
8
 3   Amantadine  10件: 240mg amantadine hcl er tablets; 320mg amantadine hcl er tablets; Ads-5102 (extended release amantadine hcl); Amantadine; Amantadine 300 mg; Amantadine hcl er; Amantadine hcl extended release; Amantadine hydrochloride; Amantadine sulfate; Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj;   D00777
 D07441 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   3件: Dopaminergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   4件:
6,
8,
13,
127
 4   Atomoxetine  1件: Atomoxetine;   D02574
 D07473 
 1件: SLC6A2   1件: Synaptic vesicle cycle   3件:
6,
8,
13
 5   Bevantolol  2件: Bevantolol; Bevantolol hydrochloride;   -   -   -   1件:
8
 6   Bupropion  2件: Bupropion; Wellbutrin (bupropion);   D00817
 D07591
 D07938 
 2件: SLC6A2, SLC6A3   2件: Dopaminergic synapse, Synaptic vesicle cycle   2件:
8,
96
 7   Citalopram  2件: 20mg daily citalopram; Citalopram;   D00822
 D07704 
 1件: SLC6A4   1件: Serotonergic synapse   3件:
8,
46,
127
 8   Creatine  4件: Creatine; Creatine monohydrate; Pyruvate, creatine, niacinamide; Creatine-13c;   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201
 9   Cysteamine  9件: Cysteamine; Cysteamine bitartrate; Cystagon® (cysteamine bitartrate); Cysteamine (mercaptamine) viscous solution; Cysteamine bitartrate (inn: mercaptamine bitartrate ); Cysteamine bitartrate delayed-release capsules (rp103); Cysteamine hydrochloride; Cystagon (cysteamine bitartrate) immediate-release capsules; Cysteamine bitartrate (cystagon);   D03634
 D03635 
 -   -   4件:
8,
19,
21,
299
 10   Dextromethorphan  9件: Dextromethorphan; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; Dextromethorphan hydrobromide; Dextromethorphan and caffeine; Dextromethorphan 30 mg;   D00848
 D03742
 D03744 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   2件: Glutamatergic synapse, Neuroactive ligand-receptor interaction   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156
 11   Digoxin  3件: Digoxin; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142;   D00298   4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4   2件: Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction   2件:
8,
46
 12   Fenofibrate  2件: Fenofibrate; Fenofibrate (insoluble drug delivery-micro particle fenofibrate (idd-p);   D00565   1件: PPARA   2件: Adipocytokine signaling pathway, PPAR signaling pathway   5件:
8,
79,
93,
94,
265
 13   GSK-356278  0件:   -   -   -   1件:
8
 14   Haloperidol  1件: Haloperidol;   D00136
 D01898 
 1件: DRD2   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   1件:
8
 15   Icosapent ethyl  0件:   D01892   -   -   1件:
8
 16   Ketoconazole  3件: Dimebon + ketoconazole; Ketoconazole; Levoketoconazole;   D00351   1件: CYP17A1   1件: Steroid hormone biosynthesis   3件:
8,
13,
75
 17   LAX-101  1件: Lax-101;   -   -   -   1件:
8
 18   Laquinimod  8件: Laquinimod; Laquinimod 0.6; Laquinimod 1.2; Laquinimod capsules 0.3 mg; Laquinimod capsules 0.6 mg; Laquinimod sodium (usan); Laquinimod tablets 0.3 mg; Laquinimod cápsulas 0.5 mg;   -   -   -   4件:
8,
13,
49,
96
 19   Latrepirdine  2件: Dimebon (latrepirdine); Latrepirdine;   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   3件: Cholinergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   1件:
8
 20   Lithium carbonate  1件: Lithium carbonate;   D00801   -   -   8件:
2,
5,
7,
8,
13,
17,
19,
127
 21   Lithium citrate  0件:   D04749   -   -   4件:
2,
5,
7,
8
 22   Memantine  3件: Memantine; Memantine (ebixa); Memantine hydrochloride;   D04905
 D08174 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   3件: Alzheimer disease, Glutamatergic synapse, Neuroactive ligand-receptor interaction   7件:
2,
6,
8,
13,
49,
127,
205
 23   Minocycline  7件: Minocycline; Glatiramer acetate with minocycline; Minocycline 100 mg film-coated tablets; Minocycline hydrochloride; Combination of minocycline and mtx or mtx alone; Lovastatin, then minocycline/lovastatin; Minocycline, then minocycline/lovastatin;   D00850
 D05045 
 -   -   14件:
2,
6,
8,
13,
46,
84,
85,
90,
94,
162,
201,
206,
280,
299
 24   Neflamapimod  1件: Neflamapimod;   D10959   4件: MAPK11, MAPK12, MAPK13, MAPK14   2件: Inflammatory mediator regulation of TRP channels, MAPK signaling pathway   1件:
8
 25   Nilotinib  8件: Cohort 1:nilotinib oral capsules (150mg or 300mg); Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1); Nilotinib; Nilotinib 150mg oral capsule [tasigna]; Nilotinib 300mg oral capsule [tasigna]; Nilotinib 150 mg; Nilotinib hydrochloride monohydrate; Nilotinib (tasigna);   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   4件: Chronic myeloid leukemia, ErbB signaling pathway, MAPK signaling pathway, Pathways in cancer   5件:
6,
8,
34,
51,
86
 26   Olanzapine  1件: Olanzapine;   D00454
 D06623 
 11件: ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Serotonergic synapse   2件:
2,
8
 27   Omeprazole  19件: Clartihromycin, amoxicillin, and omeprazole; Esomeprazole; Omeprazole; Dimebon + omeprazole; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Diclofenac + omeprazole; Esomeprazole 20 mg; Naproxen 500 mg tablets (pn 200 minus omeprazole); Pn 200 tablets (500 mg naproxen and 20 mg omeprazole); Omeprazole 20mg; Omeprazole (uk licensed generic product); Omeprazole 20 mg; Omeprazole 40 mg; Rifaximin+omeprazole+miralax; Omeprazole 20mg bid; Omeprazole magnesium; Omeprazole rectally 1mg/kg; Nexium (esomeprazole magnesium); Omeprazole 40mg capsule;   D00455
 D01207
 D05259
 D05261 
 2件: ATP4A, ATP4B   2件: Collecting duct acid secretion, Gastric acid secretion   15件:
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299
 28   Pepinemab  0件:   D11469   1件: SEMA4D   1件: Axon guidance   2件:
8,
13
 29   Phenylbutyric acid  0件:   D05868   -   -   10件:
2,
3,
6,
8,
93,
94,
244,
251,
297,
299
 30   Phosphorus  1件: Phosphorus;   -   -   -   1件:
8
 31   Pridopidine  2件: Pridopidine; Pridopidine (90 mg);   D09953   1件: DRD2   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   2件:
6,
8
 32   Quinidine  5件: Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg);   D00642
 D00643
 D02272
 D08458 
 2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   3件:
2,
8,
13
 33   Ramelteon  1件: Ramelteon;   D02689   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   3件:
6,
8,
46
 34   Resveratrol  1件: Resveratrol;   -   -   -   3件:
8,
89,
113
 35   Rilmenidine  1件: Rilmenidine;   D08482   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
8
 36   Riluzole  5件: Riluzole; Riluzole 50 mg; Riluzole 50 mg (part b); Riluzole oral soluble film; Riluzole oral soluble film (rosf) 50 mg;   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   4件: Amyotrophic lateral sclerosis (ALS), Dopaminergic synapse, Glutamatergic synapse, Neuroactive ligand-receptor interaction   7件:
2,
3,
5,
8,
13,
17,
206
 37   Risperidone  2件: Risperidone; Methylphenidate, fluoxetin, risperidone;   D00426   2件: DRD2, HTR2A   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Serotonergic synapse   5件:
8,
156,
179,
187,
206
 38   Rolipram  1件: Rolipram;   D01783   4件: PDE4A, PDE4B, PDE4C, PDE4D   1件: cAMP signaling pathway   2件:
8,
13
 39   Sage  7件: Sage; Sage leaf; Sage-217; Thn102 dosage a; Thn102 dosage b; Thn102 dosage c; Sage-718;   -   -   -   2件:
6,
8
 40   Selisistat  1件: Selisistat;   -   -   -   1件:
8
 41   Sertraline  1件: Sertraline;   D00825
 D02360 
 1件: SLC6A4   1件: Serotonergic synapse   3件:
6,
8,
206
 42   Tetrabenazine  2件: Tetrabenazine; Tetrabenazine withdrawal;   D08575   1件: SLC18A2   3件: Dopaminergic synapse, Serotonergic synapse, Synaptic vesicle cycle   1件:
8
 43   Triheptanoin  5件: Triheptanoin; Triheptanoin 1g/kg/day; Triheptanoin oil; Triheptanoina; Ux007 (triheptanoin);   D11465   -   -   10件:
2,
8,
120,
149,
156,
248,
256,
257,
317,
324
 44   Ubidecarenone  0件:   D01065   -   -   12件:
2,
5,
6,
8,
10,
46,
57,
86,
113,
193,
214,
215
 45   Ubiquinol  1件: Ubiquinol;   -   -   -   3件:
6,
8,
17
 46   Ursadiol  0件:   -   -   -   6件:
8,
20,
93,
97,
234,
299
 47   Ursodeoxycholic acid  13件: Ursodeoxycholic acid; Tauroursodeoxycholic acid; Tauroursodeoxycholic acid capsules; Udca (ursodeoxycholic acid); Ursodeoxycholic acid (urso); Ursodeoxycholic acid 300mg capsule; Ursodeoxycholic acid 300mg tablet; Ursodeoxycholic acid capsules; Ursodeoxycholic acid combination of immunosuppressive agents; Norursodeoxycholic acid; Ursodeoxycholic acid (udca); Tauroursoursodeoxycholic acid, brand name tudcabil; Ursodiol (ursodeoxycholic acid, udca);   D00734   1件: NR1H4   1件: Bile secretion   12件:
6,
8,
20,
67,
84,
93,
94,
95,
96,
97,
234,
299
 48   Valbenazine  1件: Valbenazine;   D10675   1件: SLC18A2   3件: Dopaminergic synapse, Serotonergic synapse, Synaptic vesicle cycle   1件:
8
 49   Valproic Acid  3件: Valproic acid; Valproic acid (vpa); Valproic acid and levocarnitine;   D00399   6件: ABAT, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   2件: Calcium signaling pathway, GABAergic synapse   14件:
2,
3,
5,
8,
26,
34,
65,
89,
90,
102,
222,
233,
256,
331
 50   Warfarin  4件: Warfarin; S-warfarin; The generic name is warfarin and many producers will be involved; Warfarin 10 mg;   D00564
 D01280
 D08682 
 2件: NQO1, VKORC1   1件: Ubiquinone and other terpenoid-quinone biosynthesis   10件:
6,
8,
13,
19,
46,
49,
66,
85,
88,
96

先頭へ